Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial-Reference-Cited by-同舟云学术

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

Published:1998-07 Issue:1 Volume:187 Page:69-79
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Wallack Marc K,Sivanandham Muthukumaran,Balch Charles M,Urist Marshall M,Bland Kirby I,Murray Douglas,Robinson William A,Flaherty Lawrence,Richards Jon M,Bartolucci Alfred A,Rosen Les

Publisher

Elsevier BV

Subject

Surgery

Reference40 articles.

1. Management of regional metastatic melanoma;Balch,1985

2. Induction chemotherapy using cisplatin, vinblastine and DTIC (CVD) for stage II melanoma;Legha,1990

3. Recurrent regional metastases and their management;Singletary,1985

4. Melanoma;Houghton,1995

5. Biological therapy with interleukin-2;Marincola,1995

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-03-27

2. Protein Informatics and Vaccine Development: Cancer Case Study;Current Topics in Medicinal Chemistry;2022-10

3. A systematic analysis on the clinical safety and efficacy of onco-virotherapy;Molecular Therapy - Oncolytics;2021-12

4. Repurposing Infectious Diseases Vaccines Against Cancer;Frontiers in Oncology;2021-05-13

5. Vaccine Therapies for Cancer: Then and Now;Targeted Oncology;2021-01-29